Cargando…
State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
Experience in the use of CAR T cells to treat CLL is limited, but safety and efficacy data are encouraging, suggesting that it may be possible to use CAR T cells in populations of CLL patients with particularly unfavorable prognoses. Mechanisms intrinsic to the pathophysiology of CLL undoubtedly exp...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676603/ https://www.ncbi.nlm.nih.gov/pubmed/31370892 http://dx.doi.org/10.1186/s40425-019-0686-x |